CIP2A
Protein CIP2A
Also known as: CIP2A_HUMAN, KIAA1524
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TCG1
- Gene
- CIP2A
- Ensembl
- ENSG00000163507
- Chromosome
- 3
- Canonical length
- 905 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Centrosome,Basal body,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables protein homodimerization activity and protein phosphatase inhibitor activity. Involved in broken chromosome clustering. Located in several cellular components, including cytosol; microtubule organizing center; and plasma membrane. Is active in chromosome. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
905 residues, UniProt reviewed canonical sequence.
>Q8TCG1|CIP2A
1 MDSTACLKSL LLTVSQYKAV KSEANATQLL RHLEVISGQK LTRLFTSNQI LTSECLSCLV
61 ELLEDPNISA SLILSIIGLL SQLAVDIETR DCLQNTYNLN SVLAGVVCRS SHTDSVFLQC
121 IQLLQKLTYN VKIFYSGANI DELITFLIDH IQSSEDELKM PCLGLLANLC RHNLSVQTHI
181 KTLSNVKSFY RTLITLLAHS SLTVVVFALS ILSSLTLNEE VGEKLFHARN IHQTFQLIFN
241 ILINGDGTLT RKYSVDLLMD LLKNPKIADY LTRYEHFSSC LHQVLGLLNG KDPDSSSKVL
301 ELLLAFCSVT QLRHMLTQMM FEQSPPGSAT LGSHTKCLEP TVALLRWLSQ PLDGSENCSV
361 LALELFKEIF EDVIDAANCS SADRFVTLLL PTILDQLQFT EQNLDEALTR KKCERIAKAI
421 EVLLTLCGDD TLKMHIAKIL TTVKCTTLIE QQFTYGKIDL GFGTKVADSE LCKLAADVIL
481 KTLDLINKLK PLVPGMEVSF YKILQDPRLI TPLAFALTSD NREQVQSGLR ILLEAAPLPD
541 FPALVLGESI AANNAYRQQE TEHIPRKMPW QSSNHSFPTS IKCLTPHLKD GVPGLNIEEL
601 IEKLQSGMVV KDQICDVRIS DIMDVYEMKL STLASKESRL QDLLETKALA LAQADRLIAQ
661 HRCQRTQAET EARTLASMLR EVERKNEELS VLLKAQQVES ERAQSDIEHL FQHNRKLESV
721 AEEHEILTKS YMELLQRNES TEKKNKDLQI TCDSLNKQIE TVKKLNESLK EQNEKSIAQL
781 IEKEEQRKEV QNQLVDREHK LANLHQKTKV QEEKIKTLQK EREDKEETID ILRKELSRTE
841 QIRKELSIKA SSLEVQKAQL EGRLEEKESL VKLQQEELNK HSHMIAMIHS LSGGKINPET
901 VNLSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CIP2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 3.7 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 3.7 nTPM
- lymph node: 3.5 nTPM
- thymus: 3.1 nTPM
- tonsil: 2.7 nTPM
- testis: 2.3 nTPM
- appendix: 1.9 nTPM
Single-cell type
- monocyte progenitors: 119 nCPM
- late primary spermatocytes: 110 nCPM
- neutrophil progenitors: 87 nCPM
- erythrocyte progenitors: 69 nCPM
- megakaryocyte progenitors: 54 nCPM
- early primary spermatocytes: 49 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- midbrain: 2.7 nTPM
- cerebral cortex: 2.1 nTPM
- cerebellum: 1.7 nTPM
- hypothalamus: 1.6 nTPM
- hippocampal formation: 1.1 nTPM
- basal ganglia: 1 nTPM
ReferencesPubMed · IEDB
Publications for CIP2A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- The expression of cancerous inhibitor protein phosphatase 2A in chronic rhinosinusitis with nasal polyps.
2016 · Acta Otolaryngol · RCR 0.3 · 6 citations - HapMap-based study of CIP2A gene polymorphisms and HCC susceptibility.
2012 · Oncol Lett · RCR 0.2 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Armadillo-like helical
- Armadillo-type fold
- Protein CIP2A
- CIP2A, N-terminal
- CIP2A, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CIP2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CIP2A as an antibody target. Whether an autoantibody or antibody against CIP2A could matter depends on whether native CIP2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CIP2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CIP2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...